Adam J. Krieg

2.5k total citations
36 papers, 2.0k citations indexed

About

Adam J. Krieg is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Adam J. Krieg has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Adam J. Krieg's work include Cancer, Hypoxia, and Metabolism (17 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (12 papers). Adam J. Krieg is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (12 papers). Adam J. Krieg collaborates with scholars based in United States, United Kingdom and Singapore. Adam J. Krieg's co-authors include Amato J. Giaccia, Erinn B. Rankin, Denise A. Chan, Olga V. Razorenova, Ester M. Hammond, Sully Fernandez, Katherine C. Fuh, Elizabeth Finger, Edward L. LaGory and Sacha A. Krieg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Adam J. Krieg

36 papers receiving 1.9k citations

Peers

Countries citing papers authored by Adam J. Krieg

Since Specialization

Citations

This map shows the geographic impact of Adam J. Krieg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Krieg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Krieg more than expected).

Fields of papers citing papers by Adam J. Krieg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. Krieg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Krieg. The network helps show where Adam J. Krieg may publish in the future.

Co-authorship network of co-authors of Adam J. Krieg

This figure shows the co-authorship network connecting the top 25 collaborators of Adam J. Krieg. A scholar is included among the top collaborators of Adam J. Krieg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam J. Krieg. Adam J. Krieg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling 2021 ·Nature Communications ·Eui Jung Moon, Stephano S. Mello, Caiyun G. Li, Jen‐Tsan Chi, Kaushik N. Thakkar, Jacob G. Kirkland, Edward L. LaGory, Ik Jae Lee, Anh N. Diep, Yu Rebecca Miao, Marjan Rafat, Marta Vilalta, Laura Castellini, Adam J. Krieg, Edward E. Graves, Laura D. Attardi, Amato J. Giaccia	76
2	The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type 2019 ·Gynecologic Oncology Reports ·Tanja Pejović, W. Glenn McCluggage, Adam J. Krieg, Fuhua Xu, David M. Lee, Leora Witkowski, William D. Foulkes	14
3	Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis 2019 ·Cancer Research ·Suchitra Natarajan, (unknown), (unknown), Ninna S. Rossen, Hussein Shehade, (unknown), Joshua T. Eggold, Venkatesh Krishnan, Oliver Dorigo, Adam J. Krieg, Sarah C. Heilshorn, Subarna Sinha, Katherine C. Fuh, Erinn B. Rankin	88
4	Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties 2018 ·Cancer Research ·(unknown), Harsh B. Pathak, Stephen Hyter, Ziyan Y. Pessetto, (unknown), Stefan Graw, Devin C. Koestler, Adam J. Krieg, Katherine F. Roby, Andrew K. Godwin	39
5	Histone demethylase KDM4A and KDM4B expression in granulosa cells from women undergoing in vitro fertilization 2018 ·Journal of Assisted Reproduction and Genetics ·Adam J. Krieg, (unknown), Frances Grimstad, (unknown), (unknown), (unknown), Sacha A. Krieg, Katherine F. Roby	8
6	KDM4A regulates HIF-1 levels through H3K9me3 2017 ·Scientific Reports ·(unknown), Tom E. McAllister, Katarzyna B. Leszczyńska, Shaliny Ramachandran, Adam J. Krieg, Akane Kawamura, Ester M. Hammond	39
7	Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells 2017 ·BMC Cancer ·Mercè Padró, Raymond J. Louie, Brian V. Lananna, Adam J. Krieg, Luika Timmerman, Denise A. Chan	18
8	KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage 2016 ·Nucleic Acids Research ·Laura Castellini, Eui Jung Moon, Olga V. Razorenova, Adam J. Krieg, Rie von Eyben, Amato J. Giaccia	28
9	Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET 2014 ·Proceedings of the National Academy of Sciences ·Erinn B. Rankin, Katherine C. Fuh, Laura Castellini, Kartik Viswanathan, Elizabeth Finger, Anh N. Diep, Edward L. LaGory, Mihalis S. Kariolis, Andy Chan, David Lindgren, Håkan Axelson, Yu Rebecca Miao, Adam J. Krieg, Amato J. Giaccia	210
10	The histone demethylase JMJD2B is associated with recurrent pregnancy loss and promotes decidualization of endometrial stromal cells 2013 ·Fertility and Sterility ·Sacha A. Krieg, Hong Yu, Michael J. Soares, Adam J. Krieg	2
11	Global alteration in gene expression profiles of deciduas from women with idiopathic recurrent pregnancy loss 2012 ·Molecular Human Reproduction ·Sacha A. Krieg, Xiujun Fan, Yu Hong, Qing Sang, (unknown), L.M. Westphal, Ruth B. Lathi, Adam J. Krieg, Neha Nayak	71
12	AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer 2010 ·Cancer Research ·Erinn B. Rankin, Katherine C. Fuh, (unknown), Adam J. Krieg, Margaret Musser, Jenny Yuan, Kevin Wei, Calvin J. Kuo, Teri A. Longacre, Amato J. Giaccia	181
13	Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1α Enhances Hypoxic Gene Expression and Tumor Growth 2009 ·Molecular and Cellular Biology ·Adam J. Krieg, Erinn B. Rankin, Denise A. Chan, Olga V. Razorenova, Sully Fernandez, Amato J. Giaccia	278
14	The Metastasis-Associated Gene Prl-3 Is a p53 Target Involved in Cell-Cycle Regulation 2008 ·Molecular Cell ·Shashwati Basak, Suzanne B.R. Jacobs, Adam J. Krieg, (unknown), Qi Zeng, Philipp Kaldis, Amato J. Giaccia, Laura D. Attardi	102
15	HIF Gene Expression in Cancer Therapy 2007 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Denise A. Chan, Adam J. Krieg, Sandra Turcotte, Amato J. Giaccia	22
16	Targeting the Loss of the von Hippel-Lindau Tumor Suppressor Gene in Renal Cell Carcinoma Cells 2007 ·Cancer Research ·Patrick D. Sutphin, Denise A. Chan, (unknown), Sandra Turcotte, Adam J. Krieg, Amato J. Giaccia	27
17	Checking in on Hypoxia/Reoxygenation 2006 ·Cell Cycle ·Rachel A. Freiberg, Adam J. Krieg, Amato J. Giaccia, Ester M. Hammond	22
18	Interplay between Estrogen Response Element Sequence and Ligands Controls in Vivo Binding of Estrogen Receptor to Regulated Genes 2004 ·Journal of Biological Chemistry ·Adam J. Krieg, Sacha A. Krieg, (unknown), David J. Shapiro	53
19	A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1β- Converting Enzyme (Caspase 1) 2001 ·Molecular Endocrinology ·Sacha A. Krieg, Adam J. Krieg, David J. Shapiro	32
20	Interactions of high mobility group box proteins with DNA and chromatin 1999 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Mair E. A. Churchill, Anita Changela, (unknown), Adam J. Krieg	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact